Selected research
Industry Growth & Trends
Global Dermatological Remedies Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Dermatological Remedies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dermatological Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dermatological Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dermatological Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Dermatological Remedies market include Teva, Sun Pharmaceutical, Johnson & Johnson, Qilu Pharmaceutical, Novartis, Mylan, GSK, Bayer and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dermatological Remedies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dermatological Remedies market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatological Remedies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatological Remedies.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Dermatological Remedies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dermatological Remedies Market by Company
Teva
Sun Pharmaceutical
Johnson & Johnson
Qilu Pharmaceutical
Novartis
Mylan
GSK
Bayer
Lupin
Lingrui
Galderma
Dr. Reddy's
CR SANJIU
Cipla
Bausch Health
Aurobindo
Almirall
Dermatological Remedies Segment by Type
Anti-acne
Anti-infectives
Anti Psoriasis
Corticosteroids
Others
Dermatological Remedies Segment by Application
Hospital
Clinic
Dermatological Remedies Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dermatological Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Remedies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dermatological Remedies companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-acne
- Anti-infectives
- Anti Psoriasis
- Corticosteroids
- Others
Applications
- Hospital
- Clinic
Companies covered
- Teva
- Sun Pharmaceutical
- Johnson & Johnson
- Qilu Pharmaceutical
- Novartis
- Mylan
- GSK
- Bayer
- Lupin
- Lingrui
- Galderma
- Dr. Reddy's
- CR SANJIU
- Cipla
- Bausch Health
- Aurobindo
- Almirall
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Dermatological Remedies Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Dermatological Remedies Market Size by Region (2021-2032)
- 1.4.1 Global Dermatological Remedies Market Size by Region (2021-2026)
- 1.4.2 Global Dermatological Remedies Market Size by Region (2027-2032)
- 1.5 Key Regions Dermatological Remedies Market Size (2021-2032)
- 1.5.1 North America Dermatological Remedies Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Dermatological Remedies Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Dermatological Remedies Market Size Growth Rate (2021-2032)
- 1.5.4 South America Dermatological Remedies Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Dermatological Remedies Market Size Growth Rate (2021-2032)
2 Dermatological Remedies Market by Type
- 2.1 Type Introduction
- 2.1.1 Anti-acne
- 2.1.2 Anti-infectives
- 2.1.3 Anti Psoriasis
- 2.1.4 Corticosteroids
- 2.1.5 Others
- 2.2 Global Dermatological Remedies Market Size by Type
- 2.2.1 Global Dermatological Remedies Market Size Overview by Type (2021-2032)
- 2.2.2 Global Dermatological Remedies Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Dermatological Remedies Market Size Forecasted by Type (2027-2032)
- 2.3 Global Dermatological Remedies Market Size by Regions
- 2.3.1 North America Dermatological Remedies Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Dermatological Remedies Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Dermatological Remedies Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Dermatological Remedies Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Dermatological Remedies Market Size Breakdown by Type (2021-2026)
3 Dermatological Remedies Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Dermatological Remedies Market Size by Application
- 3.2.1 Global Dermatological Remedies Market Size Overview by Application (2021-2032)
- 3.2.2 Global Dermatological Remedies Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Dermatological Remedies Market Size Forecasted by Application (2027-2032)
- 3.3 Global Dermatological Remedies Market Size by Regions
- 3.3.1 North America Dermatological Remedies Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Dermatological Remedies Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Dermatological Remedies Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Dermatological Remedies Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Dermatological Remedies Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Dermatological Remedies Industry Trends
- 4.2 Dermatological Remedies Industry Drivers
- 4.3 Dermatological Remedies Industry Opportunities and Challenges
- 4.4 Dermatological Remedies Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Dermatological Remedies Revenue (2021-2026)
- 5.2 Global Dermatological Remedies Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Dermatological Remedies Key Company Headquarters & Area Served
- 5.4 Global Dermatological Remedies Company, Product Type & Application
- 5.5 Global Dermatological Remedies Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Dermatological Remedies Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Dermatological Remedies Players Market Share by Revenue in 2025
- 5.6.3 2025 Dermatological Remedies Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Teva Dermatological Remedies Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sun Pharmaceutical
- 6.2.1 Sun Pharmaceutical Company Information
- 6.2.2 Sun Pharmaceutical Business Overview
- 6.2.3 Sun Pharmaceutical Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sun Pharmaceutical Dermatological Remedies Product Portfolio
- 6.2.5 Sun Pharmaceutical Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Johnson & Johnson Dermatological Remedies Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Qilu Pharmaceutical
- 6.4.1 Qilu Pharmaceutical Company Information
- 6.4.2 Qilu Pharmaceutical Business Overview
- 6.4.3 Qilu Pharmaceutical Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Qilu Pharmaceutical Dermatological Remedies Product Portfolio
- 6.4.5 Qilu Pharmaceutical Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Novartis Dermatological Remedies Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Mylan
- 6.6.1 Mylan Company Information
- 6.6.2 Mylan Business Overview
- 6.6.3 Mylan Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Mylan Dermatological Remedies Product Portfolio
- 6.6.5 Mylan Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 GSK Dermatological Remedies Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 Bayer
- 6.8.1 Bayer Company Information
- 6.8.2 Bayer Business Overview
- 6.8.3 Bayer Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Bayer Dermatological Remedies Product Portfolio
- 6.8.5 Bayer Recent Developments
- 6.9 Lupin
- 6.9.1 Lupin Company Information
- 6.9.2 Lupin Business Overview
- 6.9.3 Lupin Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Lupin Dermatological Remedies Product Portfolio
- 6.9.5 Lupin Recent Developments
- 6.10 Lingrui
- 6.10.1 Lingrui Company Information
- 6.10.2 Lingrui Business Overview
- 6.10.3 Lingrui Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Lingrui Dermatological Remedies Product Portfolio
- 6.10.5 Lingrui Recent Developments
- 6.11 Galderma
- 6.11.1 Galderma Company Information
- 6.11.2 Galderma Business Overview
- 6.11.3 Galderma Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Galderma Dermatological Remedies Product Portfolio
- 6.11.5 Galderma Recent Developments
- 6.12 Dr. Reddy's
- 6.12.1 Dr. Reddy's Company Information
- 6.12.2 Dr. Reddy's Business Overview
- 6.12.3 Dr. Reddy's Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Dr. Reddy's Dermatological Remedies Product Portfolio
- 6.12.5 Dr. Reddy's Recent Developments
- 6.13 CR SANJIU
- 6.13.1 CR SANJIU Company Information
- 6.13.2 CR SANJIU Business Overview
- 6.13.3 CR SANJIU Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 CR SANJIU Dermatological Remedies Product Portfolio
- 6.13.5 CR SANJIU Recent Developments
- 6.14 Cipla
- 6.14.1 Cipla Company Information
- 6.14.2 Cipla Business Overview
- 6.14.3 Cipla Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Cipla Dermatological Remedies Product Portfolio
- 6.14.5 Cipla Recent Developments
- 6.15 Bausch Health
- 6.15.1 Bausch Health Company Information
- 6.15.2 Bausch Health Business Overview
- 6.15.3 Bausch Health Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bausch Health Dermatological Remedies Product Portfolio
- 6.15.5 Bausch Health Recent Developments
- 6.16 Aurobindo
- 6.16.1 Aurobindo Company Information
- 6.16.2 Aurobindo Business Overview
- 6.16.3 Aurobindo Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Aurobindo Dermatological Remedies Product Portfolio
- 6.16.5 Aurobindo Recent Developments
- 6.17 Almirall
- 6.17.1 Almirall Company Information
- 6.17.2 Almirall Business Overview
- 6.17.3 Almirall Dermatological Remedies Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Almirall Dermatological Remedies Product Portfolio
- 6.17.5 Almirall Recent Developments
7 North America
- 7.1 North America Dermatological Remedies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Dermatological Remedies Market Size by Country (2021-2026)
- 7.3 North America Dermatological Remedies Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Dermatological Remedies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Dermatological Remedies Market Size by Country (2021-2026)
- 8.3 Europe Dermatological Remedies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dermatological Remedies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Dermatological Remedies Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Dermatological Remedies Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Dermatological Remedies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Dermatological Remedies Market Size by Country (2021-2026)
- 10.3 South America Dermatological Remedies Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dermatological Remedies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Dermatological Remedies Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Dermatological Remedies Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst